Stock listing

XE9 Stock Price, News, Filings & Events — Xencor, Inc.

Selected listing: XE9 · TRADEGATE · EUR · DE

The XE9:TRADEGATE listing represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Recent news highlights the company's advancements in clinical trials and collaborations aimed at enhancing its therapeutic offerings. Investors can find the latest filings and updates on upcoming events that may impact the company's market position. Xencor continues to navigate the evolving landscape of biopharmaceuticals, positioning itself for future growth.